Himension Capital (Singapore)’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.84M | Sell |
729,421
-23,255
| -3% | -$218K | 0.53% | 24 |
|
|
2025
Q1 | $5.35M | Sell |
752,676
-233,039
| -24% | -$1.66M | 0.46% | 24 |
|
|
2024
Q4 | $11.5M | Sell |
985,715
-89,996
| -8% | -$1.05M | 0.8% | 16 |
|
|
2024
Q3 | $22.1M | Buy |
1,075,711
+45,729
| +4% | +$940K | 1.73% | 11 |
|
|
2024
Q2 | $23.1M | Sell |
1,029,982
-639
| -0.1% | -$14.3K | 1.63% | 12 |
|
|
2024
Q1 | $28.4M | Hold |
1,030,621
| – | – | 2.13% | 7 |
|
|
2023
Q4 | $31.4M | Sell |
1,030,621
-114,470
| -10% | -$3.49M | 2.85% | 9 |
|
|
2023
Q3 | $36.2M | Hold |
1,145,091
| – | – | 3.72% | 7 |
|
|
2023
Q2 | $46.7M | Hold |
1,145,091
| – | – | 4.26% | 7 |
|
|
2023
Q1 | $42.7M | Hold |
1,145,091
| – | – | 3.83% | 6 |
|
|
2022
Q4 | $40M | Sell |
1,145,091
-46,102
| -4% | -$1.61M | 5.34% | 7 |
|
|
2022
Q3 | $66.7M | Sell |
1,191,193
-25,147
| -2% | -$1.41M | 7.07% | 6 |
|
|
2022
Q2 | $63M | Buy |
1,216,340
+472,180
| +63% | +$24.4M | 7.04% | 8 |
|
|
2022
Q1 | $54.1M | Buy |
744,160
+153,920
| +26% | +$11.2M | 5.79% | 9 |
|
|
2021
Q4 | $69.8M | Buy |
590,240
+169,381
| +40% | +$20M | 5.34% | 7 |
|
|
2021
Q3 | $56.5M | Buy |
420,859
+120,532
| +40% | +$16.2M | 4.4% | 7 |
|
|
2021
Q2 | $48.6M | Buy |
300,327
+277,207
| +1,199% | +$44.9M | 4.72% | 6 |
|
|
2021
Q1 | $1.86M | Buy |
+23,120
| New | +$1.86M | 0.4% | 13 |
|